Ms. Shubhra Bansal – CDSA

Ms. Shubhra Bansal has joined CDSA as Director, Clinical Portfolio Management. She holds a master’s degree in Medical Elementology and Toxicology and has experience of over 18 years in Biopharmaceutical and CRO Industry (Eli Lilly , Inotek Pharmaceuticals, PPD) with in-depth knowledge of managing and executing global/Indian clinical operations, project management with APAC regional management (India, Japan, Thailand, Nepal, Srilanka, Taiwan, Australia, Malaysia, Philippines, Honk Kong, China and Singapore). She is member of Indian Society of Clinical Research (ISCR) and has also supported the academic researchers and SMEs as an independent consultant with Biotech Consortium India Limited (BCIL). She has been actively involved in development of online platform for clinical research training and the same remains, one of the key area of interest. She has served as part of Indian leadership team in her previous organizations and has  wide experience of managing studies and clinical development services (start up, study conduct, study closure, data management, risk based monitoring), phase I – through phase IV, observational studies, post marketing surveillance, in numerous indications including: Lupus, Diabetes, Refractory Partial Seizures, AML, Sepsis, Erectile Dysfunction, Myocardial Infarction, Macular Oedema, Cardiac Bypass, Oncology, Vaccines (Malaria, Dengue), Leishmaniosis and public health research.

NCR Biotech Science Cluster
3rd Milestone, Faridabad – Gurgaon Expressway, PO box #04, Faridabad – 121001 (HARYANA)

0129-2876300